Biomerica reports real-world data showing IBS therapy effectiveness Feb 26, 2026 08:20AM
Henry Schein (HSIC) PT Raised to $87 at Leerink Partners Feb 24, 2026 02:24PM
Henry Schein (HSIC) Tops Q4 EPS by 4c ; Offers Guidance Feb 24, 2026 06:07AM
Baird Upgrades Henry Schein (HSIC) to Outperform Feb 23, 2026 01:56AM
Henry Schein signs exclusive deal for CytoChip's blood analyzer Jan 15, 2026 10:00AM


Dec 23, 2025 04:06PM Henry Schein expects to name new CEO by mid-January 2026
Nov 11, 2025 08:18AM BofA lists 16 stock opportunities away from AI
Nov 4, 2025 06:01AM Henry Schein (HSIC) Tops Q3 EPS by 10c, provides guidance
Nov 3, 2025 08:05AM Henry Schein One partners with AWS to integrate AI into dental platforms
Oct 16, 2025 08:19AM Biomerica partners with Henry Schein to market IBS test in US
Oct 14, 2025 04:01PM CFRA Downgrades Henry Schein (HSIC) to Strong Sell
Sep 23, 2025 07:36AM Piper Sandler Reiterates Overweight Rating on Henry Schein (HSIC)
Aug 26, 2025 05:32AM Evercore ISI Upgrades Henry Schein (HSIC) to Outperform
Aug 5, 2025 06:04AM Henry Schein (HSIC) Misses Q2 EPS by 9c, Misses on Revenue; Offers FY25 EPS Guidance
Jul 25, 2025 03:42AM Stifel Downgrades Henry Schein (HSIC) to Hold
Jul 14, 2025 02:05AM Baird Downgrades Henry Schein (HSIC) to Neutral
May 30, 2025 08:34AM Piper Sandler Highlights 'Best Value Stocks' in Medical Technology
May 16, 2025 04:11PM Henry Schein (HSIC) announces KKR completes strategic investment, appoints Dan Daniel to Board
May 5, 2025 06:03AM Henry Schein (HSIC) Tops Q1 EPS by 3c, provides guidance
Mar 25, 2025 04:45AM Henry Schein (HSIC) PT Lowered to $76 at Mizuho
Mar 10, 2025 02:50PM Henry Schein (HSIC) April 75 puts and April 80 calls active
Feb 25, 2025 06:06AM Henry Schein (HSIC) Misses Q4 EPS by 4c, provides guidance
Feb 14, 2025 05:33AM Wel;ls Fargo Starts Henry Schein (HSIC) Equal-weight
Jan 30, 2025 06:42AM Henry Schein (HSIC) PT Raised to $78 at Mizuho
Jan 29, 2025 07:02AM Henry Schein (HSIC) Announces Strategic Investment by KKR (KKR), Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance
Jan 22, 2025 04:27PM Activist Ananym Plans to Launch Proxy Fight at Henry Schein (HSIC) - Reuters
Jan 15, 2025 06:31AM Henry Schein (HSIC) Completes Acquisition of Acentus
Dec 4, 2024 09:20AM Mizuho Starts Henry Schein (HSIC) at Neutral
Dec 3, 2024 03:32PM Henry Schein (HSIC) spreader of 2K contracts of December 70 puts and 1500 December 75 puts
Nov 20, 2024 06:30AM Henry Schein (HSIC) to Acquire Acentus
Nov 19, 2024 07:58AM Piper Sandler Reiterates Overweight Rating on Henry Schein (HSIC)
Nov 18, 2024 01:35PM Activist Investor Ananym Capital Pushes for Changes at Henry Schein (HSIC) - Reuters
Nov 5, 2024 06:02AM Henry Schein (HSIC) Tops Q3 EPS by 15c, provides guidance
Nov 2, 2024 04:00AM The election implications for healthcare technology and distribution stocks - BofA
Oct 17, 2024 08:04AM Zentek (ZTEK) Provides Market Update on ZenGUARD Antimicrobial Surgical Masks
Oct 17, 2024 08:00AM Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks
Oct 15, 2024 04:26PM CFRA Downgrades Henry Schein (HSIC) to Sell ,'see better near-term upside in pharmaceutical distributors'
Aug 6, 2024 06:09AM Henry Schein (HSIC) Tops Q2 EPS by 1c ; Offers Guidance
Jul 22, 2024 03:32AM Baird Upgrades Henry Schein (HSIC) to Outperform